Pain Detection and Interception in Neonates

NCT ID: NCT00447824

Last Updated: 2007-03-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-03-31

Study Completion Date

2009-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hypothesis:

1. May the introduction of NIDCAP during blood sample reduced pain in neonates during blood sample
2. Compare the effect of venous and capillary blood sample method

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

introducing the: Newborn Individualized Developmental Care and Assessment Program

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Detection Pain Intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Introduction of better conditions during blood sampling

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Born gestation age 31-36

Exclusion Criteria

* Infection, respiratory distress
Minimum Eligible Age

31 Weeks

Maximum Eligible Age

36 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helse sor

UNKNOWN

Sponsor Role collaborator

Sorlandet Hospital HF

OTHER_GOV

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Knut G Hernes, Dr

Role: STUDY_CHAIR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sorlandet Hospital SSHF

Kristiansand, Vest Agder, Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Knut G Hernes, Dr

Role: CONTACT

+(47) 957 99999

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S-06471a

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.